PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive: To determine whether PSMD1 or PSMD3 regulates NF-κB activation in CML and TKI resistance, we used shRNAs to knockdown their expression in TKI-sensitive versus TKI-resistant CML cells.